Pathstone Family Office’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Pathstone Family Office's ELV Position: Q3 2023 in Review
Pathstone Family Office increased its Elevance Health (ELV) stake by 72% in Q3 2023, buying an estimated $4.22M and bringing the position to 22,208 shares worth $9.67M. The position accounts for 0.07% of the portfolio, ranked #176.
Pathstone Family Office first reported a position in ELV in Q1 2017 and has held it in 18 quarters since. The position peaked at $15.5M in Q4 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.
- Pathstone Family Office held 22,208 shares of Elevance Health worth $9.67M as of Q3 2023.
- Pathstone Family Office bought 9,305 Elevance Health shares in Q3 2023, an estimated $4.22M.
- Elevance Health made up 0.07% of Pathstone Family Office's portfolio in Q3 2023, its #176 holding.
- Pathstone Family Office first reported a position in Elevance Health in Q1 2017 and has held it in 18 quarters since.
- Pathstone Family Office's Elevance Health position peaked at $15.5M in Q4 2022.
- 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.
Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.